Giovanni Battista Pedrazzini
Twenty-year trends in the prevalence of modifiable cardiovascular risk factors in young acute coronary syndrome patients hospitalized in Switzerland.
Mahendiran T, Hoepli A, Foster-Witassek F, Rickli H, Roffi M, Eberli F, Pedrazzini G, Jeger R, Radovanovic D, Fournier S, AMIS Plus Investigators. Twenty-year trends in the prevalence of modifiable cardiovascular risk factors in young acute coronary syndrome patients hospitalized in Switzerland. Eur J Prev Cardiol 2023; 30:1504-1512.
10.10.2023Twenty-year trends in the prevalence of modifiable cardiovascular risk factors in young acute coronary syndrome patients hospitalized in Switzerland.
10.10.2023Eur J Prev Cardiol 2023; 30:1504-1512
Mahendiran Thabo, Hoepli André, Foster-Witassek Fabienne, Rickli Hans, Roffi Marco, Eberli Franz R, Pedrazzini Giovanni Battista, Jeger Raban V, Radovanovic Dragana, Fournier Stephane, AMIS Plus Investigators
Patients With AMI and Severely Reduced LVEF, a Well-Defined, Still Extremely Vulnerable Population (Insights from AMIS Plus Registry).
Roberto M, Hoepli A, Cattaneo M, Radovanovic D, Rickli H, Erne P, Pedrazzini G, Moccetti M. Patients With AMI and Severely Reduced LVEF, a Well-Defined, Still Extremely Vulnerable Population (Insights from AMIS Plus Registry). Am J Cardiol 2023; 200:190-201.
20.06.2023Patients With AMI and Severely Reduced LVEF, a Well-Defined, Still Extremely Vulnerable Population (Insights from AMIS Plus Registry).
20.06.2023Am J Cardiol 2023; 200:190-201
Roberto Marco, Hoepli André, Cattaneo Mattia, Radovanovic Dragana, Rickli Hans, Erne Paul, Pedrazzini Giovanni Battista, Moccetti Marco
Prognostic value of low heart rates in patients admitted with acute myocardial infarction.
Biasco L, Foster-Witassek F, Radovanovic D, Dittli P, Tersalvi G, Rickli H, Roffi M, Eberli F, Jeger R, Erne P, Pedrazzini G. Prognostic value of low heart rates in patients admitted with acute myocardial infarction. Rev Esp Cardiol (Engl Ed) 2023; 76:626-634.
04.02.2023Prognostic value of low heart rates in patients admitted with acute myocardial infarction.
04.02.2023Rev Esp Cardiol (Engl Ed) 2023; 76:626-634
Biasco Luigi, Foster-Witassek Fabienne, Radovanovic Dragana, Dittli Philip, Tersalvi Gregorio, Rickli Hans, Roffi Marco, Eberli Franz R, Jeger Raban V, Erne Paul, Pedrazzini Giovanni Battista
Dual antiplatelet therapy is under-prescribed in patients with surgically treated acute myocardial infarction
Roberto M, Radovanovic D, Buttà C, Tersalvi G, Krüll J, Erne P, Rickli H, Pedrazzini G, Moccetti M. Dual antiplatelet therapy is under-prescribed in patients with surgically treated acute myocardial infarction. Interact Cardiovasc Thorac Surg 2021; 33:687-694.
29.01.2021Dual antiplatelet therapy is under-prescribed in patients with surgically treated acute myocardial infarction
29.01.2021Interact Cardiovasc Thorac Surg 2021; 33:687-694
Roberto Marco, Radovanovic Dragana, Buttà Carmelo, Tersalvi Gregorio, Krüll Joël, Erne Paul, Rickli Hans, Pedrazzini Giovanni Battista, Moccetti Marco